MORE►
biotech
[Graphic: JLL]
JLL’s DFW Life Science Snapshot: What’s Driving the North Texas Biotech Boom
by Lance Murray | Oct 4, 2022
The North Texas biotech boom just keeps booming—and a new "DFW Life Science Snapshot" from JLL shows why. From the Biotech+ Hub at Pegasus Park to a string of accelerators to local universities, DFW Airport, and more, here's a deep dive into what's behind the boom.
"We are showing up in the rankings and in the data," says Mike Rosa of the Dallas Regional Chamber. "It results in more opportunities and more looks for us."
by Kevin Cummings |
Sep 27, 2022
Dallas-based Colossal Biosciences, the de-extinction company behind plans to bring back the woolly mammoth and thylacine, developed its own software solution "after reviewing everything available on the market." Now it's sharing the platform with the launch of Form Bio.
The spinout's technology tools can help drive the “entire molecular revolution” that is occurring in the life sciences and biotech space, in addition to bolstering the Lone Star state as a hub for the industry, says Chief Strategy Officer Claire Aldridge.
The spinout's technology tools can help drive the “entire molecular revolution” that is occurring in the life sciences and biotech space, in addition to bolstering the Lone Star state as a hub for the industry, says Chief Strategy Officer Claire Aldridge.
MORE►
by Lance Murray |
Aug 20, 2022
Brannon Morisoli will join the team at a time when life science is booming in North Texas. Most recently, Dallas-Fort Worth ranked for the first time in the "Top 20 U.S. metros for life science" 2022 report by CommercialEdge.
MORE►
by Sandra Engelland |
Aug 3, 2022
Top North Texas healthcare and life science employers—including UT Southwestern, McKesson, Evolve Biologics, Texas Health Resources, and more—have already signed up to hire 1,100 biotech workers from the groundbreaking program.
27,000 workers have made Dallas-Fort Worth a Top 20 U.S. metro for life sciences companies. As the boom continues, they’ll need company. Here's how the grant will help Dallas College and other local higher ed institutions step up to provide it—and why a CEO at Lyda Hill Philantrhopies calls it a "game changer."
27,000 workers have made Dallas-Fort Worth a Top 20 U.S. metro for life sciences companies. As the boom continues, they’ll need company. Here's how the grant will help Dallas College and other local higher ed institutions step up to provide it—and why a CEO at Lyda Hill Philantrhopies calls it a "game changer."
MORE►
Left to right: Dr. Shehnaaz Suliman, CEO and board member of ReCode; and David Lockhart, president and chief science officer. [Photos: Jennifer Leahy]
Dallas-Founded Biopharma Firm Raises $120M to Expand its Pipeline
by Kevin Cummings | Jun 29, 2022
ReCode Therapeutics, a biopharmaceutical startup using a non-viral lipid nanoparticle delivery platform for gene therapies, has closed a $120 million extension to a funding round it raised last year to help bring its lead programs to human trials and “follow the science” to target new diseases.
With a research team working out of BioLabs' life sciences facility at Pegasus Park, ReCode aims to grow its global team from about 70 to 100 over the next year.
MORE►
by Dave Moore |
May 24, 2022
"It takes time" to establish a track record, Jorge Varela says, and the region is starting to see a series of biotech successes and spinoffs that will elevate the region's profile as a biotech hub.
According to a panel of experts at Urban Land Institute's 2022 spring meeting, here are factors drawing biotech to DFW.
According to a panel of experts at Urban Land Institute's 2022 spring meeting, here are factors drawing biotech to DFW.
MORE►
![Southwestern Medical Foundation President and CEO Kathleen Gibson has joined the board of nonprofit LaunchBio. [Image: Southwestern Medical Foundation; istockphoto]](https://s24806.pcdn.co/wp-content/uploads/2022/04/Kathleen-Gibson-LaunchBio-board-360x203.jpg)
by Quincy Preston |
Apr 29, 2022
LaunchBio, a life science and biotech nonprofit that expanded to North Texas in 2021, has announced four new board members, including Dallas-based Kathleen Gibson, along with a new board chair.
LaunchBio is working to accelerate the entrepreneurial support network in the region through collaborations with BioLabs, Lyda Hill Philanthropies, J. Small Investments, BioNTX, DLA Piper, and others.
LaunchBio is working to accelerate the entrepreneurial support network in the region through collaborations with BioLabs, Lyda Hill Philanthropies, J. Small Investments, BioNTX, DLA Piper, and others.
MORE►
by Kevin Cummings |
Apr 27, 2022
Through a three-year partnership called the North Texas Funders Initiative, The Dallas Foundation and local leadership impact nonprofit RevJen Group, along with others including Lyda Hill Philanthropies, will bring leadership development training to over 300 nonprofit leaders each year.
MORE►
Frank Stonebanks, CEO of Renibus Therapeutics. [Photo: Renibus]
With New Funding and CEO, This Southlake Biotech is Looking to Solve Kidney Disease
by Kevin Cummings | Feb 16, 2022
Renibus Therapeutics, which focuses on treatments for acute and chronic kidney diseases, announced closing a $35 million Series A funding round. Its new CEO, Frank Stonebanks, says "Renibus has arrived at a critical inflection point in its commitment to transform the prevention and treatment of kidney diseases."
MORE►
by Dave Moore |
Dec 6, 2021
Mississauga, Ontario-based Evolve Biologics is a producer of plasma-derived therapeutics. The firm's CEO says the new, state-of-the-art, 200,000-SF Sachse facility "will be the foundation of our future growth and global strategy," with the capacity to process 1 million liters of plasma annually and a planned expansion to 2 million liters.
MORE►
Dallas-Based Vaxxinity Prepares for $100M IPO; Aims to Turn Immune Systems Into ‘Antibody Factories’
by David Seeley |
Nov 8, 2021
Vaxxinity's COVID-19 vaccine candidate is "super safe and mild and doesn’t bring recipients down for a couple of days with flu-like symptoms," says the company's co-founder and CEO, Mei Mei Hu. Unlike mRNA vaccines from Modern and Pfizer, Vaxxinity says its protein peptide-based platform is based on tech that led to a vaccine for foot-and-mouth disease in livestock.
MORE►
by Alex Edwards |
Oct 14, 2021
It's the San Franciso company's first office in Texas. Verily expects to hire as many as 115 employees by the end of 2022.
MORE►
Dennis K. Stone [Photo: BioNTX]
Nominate Now: BioNTX Dennis K. Stone Award Recognizes Positive Impact in North Texas Biotech and Life Science Research
by bionorthTX | Sep 14, 2021
Deadline for nominations is Friday, September 17. The 2021 award, sponsored by BioLabs at Pegasus Park, will be presented on September 30 at the iC3 Life Science Summit.
The impact that Dr. Dennis K. Stone left on the DFW biotech industry is, without doubt, immeasurable, says BioNTX. Past recipients of the award that honors his memory are Phil Ralston, Lyda Hill, Darlene Boudreaux, Paul Dorman, and Hubert Zajicek.
MORE►
by Alex Edwards |
Aug 25, 2021
There, Signature Biologics will manufacture perinatal-derived products that improve the body's natural healing processes in wound, musculoskeletal, and pain management applications.
MORE►
by Alex Edwards |
Aug 10, 2021
A mid-December opening is planned for BioLabs' first central U.S. location in Dallas. Inside the Biotech+ Hub at Pegasus Park, BioLabs will serve as the key operator of the biotech laboratory and 37,000-square-foot flexible life science coworking facility.
MORE►
by David Seeley |
Jun 22, 2021
Nanoscope Therapeutics successfully treated 11 patients blinded by advanced retinitis pigmentosa (RP). A single intravitreal injection produced positive results that persisted through one year. The startup plans a Phase 2b trial this summer and plans to develop gene therapies to treat more common retinal diseases—like dry age-related macular degeneration.
MORE►
![Erica Kosemund, Chief Brand Officer, Choctaw Nation of Oklahoma; Gillian Breidenbach, Chief Partnership Officer, North Texas FWC Organizing Committee; Chief Gary Batton, Chief of Choctaw Nation of Oklahoma; Monica Paul, Executive Director of Dallas Sports Commission and President of North Texas FWC Organizing Committee; John Hobbs, Senior Executive Officer of Communications, Choctaw Nation of Oklahoma; and Heidi Grant, Senior Executive Officer of Commerce Administration, Choctaw Nation of Oklahoma, celebrate Choctaw Casinos & Resorts becoming an Official Dallas World Cup 2026 Host City Supporter. [Photo: North Texas FWC Organizing Committee/Choctaw Casinos & Resorts]](https://s24806.pcdn.co/wp-content/uploads/2025/12/FIFA-Choctaw-dec-2025.jpg)
